Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Go back to Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Avadel Pharma (AVDL) Misses Q2 EPS by 65c

August 9, 2022 7:22 AM EDT

Avadel Pharma (NASDAQ: AVDL) reported Q2 EPS of ($1.07), $0.65 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

... More